Targeted therapies for metastatic colorectal cancer (mCRC): A systematic review of cost-effectiveness (CE).
Tanya G. Bentley
Research Funding - Bristol-Myers Squibb
Michael Samuel Broder
Research Funding - Bristol-Myers Squibb
Lopamudra Das
Research Funding - Bristol-Myers Squibb
Jesse Ortendahl
Research Funding - Bristol-Myers Squibb
Yun Su
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Samuel Wagner
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb